Plus Therapeutics reported $8.57M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Baxter International USD 3.59B 102M Jun/2026
Cerus USD 100.8M 12.37M Dec/2025
Dr.Reddys Laboratories INR 157.34B 10.13B Jun/2026
Haemonetics USD 263.24M 19.36M Jun/2026
Northwest Biotherapeutics USD 82.97M 4.93M Mar/2026
Plus Therapeutics USD 8.57M 612K Jun/2026
Sanofi EUR 31.93B 1.92B Jun/2026
Starpharma Holdings AUD 4.61M 614K Dec/2025
Sun Pharmaceuticals INR 226.22B 7.93B Mar/2026
Teva Pharmaceutical Industries USD 15.65B 2.11B Jun/2026